Redeye: Egetis Therapeutics (Q4 review): US approval on the horizon
Idag, 10:56
Idag, 10:56
Redeye’s analyst just published a Research Update on Egetis Therapeutics.
Click here to read the article
Make sure to add Egetis Therapeutics to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se
Attachments
Idag, 10:56
Redeye’s analyst just published a Research Update on Egetis Therapeutics.
Click here to read the article
Make sure to add Egetis Therapeutics to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se
Attachments
Analys
Börser
Analys
Börser
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
3 098,44